Jefferies Group LLC set a $86.00 price objective on CVS Health Corporation (NYSE:CVS) in a research report sent to investors on Wednesday morning. The brokerage currently has a hold rating on the pharmacy operator’s stock.

Other equities analysts also recently issued reports about the company. Leerink Swann set a $90.00 target price on CVS Health Corporation and gave the company a buy rating in a research note on Tuesday, June 27th. Guggenheim restated a buy rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Oppenheimer Holdings, Inc. restated a buy rating and issued a $95.00 target price on shares of CVS Health Corporation in a research note on Monday, October 9th. SunTrust Banks, Inc. set a $85.00 target price on CVS Health Corporation and gave the company a buy rating in a research note on Thursday, October 12th. Finally, Needham & Company LLC restated a hold rating on shares of CVS Health Corporation in a research note on Sunday, September 10th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating to the stock. The company has a consensus rating of Buy and a consensus target price of $89.68.

CVS Health Corporation (NYSE CVS) traded up 0.93% during mid-day trading on Wednesday, hitting $74.79. The stock had a trading volume of 3,050,655 shares. The firm has a market cap of $76.03 billion, a PE ratio of 14.90 and a beta of 0.92. CVS Health Corporation has a 12-month low of $69.30 and a 12-month high of $88.84. The company has a 50-day moving average of $78.94 and a 200-day moving average of $78.75.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company had revenue of $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. During the same period in the previous year, the firm posted $1.32 earnings per share. CVS Health Corporation’s quarterly revenue was up 4.5% compared to the same quarter last year. Analysts expect that CVS Health Corporation will post $5.88 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “CVS Health Corporation (CVS) Given a $86.00 Price Target at Jefferies Group LLC” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/10/19/cvs-health-corporation-cvs-given-a-86-00-price-target-at-jefferies-group-llc.html.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.70%. CVS Health Corporation’s payout ratio is 39.92%.

In related news, EVP Thomas M. Moriarty sold 90,267 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the sale, the executive vice president now owns 70,102 shares of the company’s stock, valued at $5,580,820.22. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Richard J. Swift sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total value of $199,050.00. Following the sale, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The disclosure for this sale can be found here. In the last three months, insiders have sold 716,625 shares of company stock worth $58,318,431. 0.61% of the stock is owned by corporate insiders.

Large investors have recently made changes to their positions in the stock. Jackson Grant Investment Advisers Inc. grew its position in CVS Health Corporation by 0.6% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 2,881 shares of the pharmacy operator’s stock worth $232,000 after buying an additional 18 shares during the last quarter. Keel Point LLC grew its position in CVS Health Corporation by 0.7% in the first quarter. Keel Point LLC now owns 3,296 shares of the pharmacy operator’s stock worth $259,000 after buying an additional 22 shares during the last quarter. First City Capital Management Inc. grew its position in CVS Health Corporation by 0.3% in the first quarter. First City Capital Management Inc. now owns 12,771 shares of the pharmacy operator’s stock worth $1,003,000 after buying an additional 40 shares during the last quarter. Elefante Mark B grew its position in CVS Health Corporation by 0.7% in the second quarter. Elefante Mark B now owns 6,400 shares of the pharmacy operator’s stock worth $515,000 after buying an additional 45 shares during the last quarter. Finally, Traynor Capital Management Inc. grew its position in CVS Health Corporation by 1.3% in the second quarter. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator’s stock worth $290,000 after buying an additional 48 shares during the last quarter. 81.46% of the stock is currently owned by hedge funds and other institutional investors.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Analyst Recommendations for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.